SAB Biotherapeutics (SABS) Amortization of Deferred Charges (2021 - 2022)
SAB Biotherapeutics (SABS) reported Amortization of Deferred Charges of $24717.0 for Q3 2022, down 40.09% on a YoY basis from $41259.0 in Q3 2021, and down 22.3% quarter-over-quarter from $31809.0 in Q2 2022.
SAB Biotherapeutics (SABS) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends
SAB Biotherapeutics has reported Amortization of Deferred Charges for 2 years, with the latest figure at $24717.0 in Q3 2022.
- For the quarter ending Q3 2022, Amortization of Deferred Charges fell 40.09% year-over-year to $24717.0; the trailing twelve-month figure through Sep 2022 stood at $138939.0 (changed N/A YoY), and the FY2021 full-year result was $164983.0, changed 0.03% from the prior year.
- Amortization of Deferred Charges for Q3 2022 stood at $24717.0, down from $31809.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $41259.0 in Q1 2021, with the low at $24717.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | SAB Biotherapeutics | 214.77 Mn | 214.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 24,717.00 |
| Sep 30, 2022 | 24,717.00 |
| Jun 30, 2022 | 31,809.00 |
| Jun 30, 2022 | 31,809.00 |
| Mar 31, 2022 | 41,207.00 |
| Mar 31, 2022 | 41,207.00 |
| Dec 31, 2021 | 41,206.00 |
| Dec 31, 2021 | 41,206.00 |
| Sep 30, 2021 | 41,259.00 |
| Sep 30, 2021 | 41,259.00 |
| Jun 30, 2021 | 41,259.00 |
| Jun 30, 2021 | 41,259.00 |
| Mar 31, 2021 | 41,259.00 |
| Mar 31, 2021 | 41,259.00 |